GlassScriptPhysician profile
Anand M Prem
NPI 1962423715
$13,066.12
in general payments reported to CMS, 2019-2025
26 companies · $2,343 in 2025
The $2,343 reported for 2025 was more than what 85% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,074 · 2020: $823 · 2021: $2,013 · 2022: $3,165 · 2023: $1,542 · 2024: $2,105 · 2025: $2,343.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,286 · Travel and Lodging: $706.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,285.61 |
| Travel and Lodging | $705.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,332.88 | 2019-2025 | Eterna, Proclaim, Prodigy |
| Boston Scientific Corporation | $3,000.27 | 2019-2025 | General - Pain Management, Intracept, Wavewriter Alpha Prime 16 |
| Medtronic, INC. | $1,835.71 | 2021-2025 | Intellis Adaptivestim, Vanta Adaptivestim, Kyphon Express II Kyphopak Tray |
| Nevro Corp. | $1,437.83 | 2019-2024 | Senza |
| Nalu Medical, INC. | $650.55 | 2022-2025 | Nalu Neurostimulation System |
| Pacira Pharmaceuticals Incorporated | $547.82 | 2023 | Iovera |
| Spr Therapeutics, INC | $386.40 | 2019-2025 | Sprint Pns System |
| Avanos Medical | $272.69 | 2019-2025 | Coolief Cooled Radiofrequency |
| Biotronik Nro, INC. | $272.31 | 2025 | Prospera |
| Si-Bone, INC. | $224.39 | 2024 | |
| Averitas Pharma INC. | $165.07 | 2023-2025 | Qutenza |
| Painteq LLC | $153.38 | 2021 | |
| Merck Sharp & Dohme LLC | $134.36 | 2020-2025 | Bridion |
| Saluda Medical Americas, INC. | $113.33 | 2023 | Evoke Scs |
| Allergan, INC. | $92.96 | 2019-2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $84.99 | 2019 | |
| Medtronic USA, INC. | $84.92 | 2019-2020 | |
| Baudax Bio INC. | $64.13 | 2021 | |
| Globus Medical, INC. | $58.35 | 2025 | Senza, Vyrsa V1 |
| Novartis Pharmaceuticals Corporation | $49.00 | 2019 | |
| Lundbeck LLC | $26.25 | 2025 | Vyepti |
| Eagle Pharmaceuticals, INC. | $22.71 | 2024 | |
| Solventum Corporation | $16.37 | 2024 | Bair Hugger |
| Grt US Holding, INC. | $15.28 | 2022 | |
| Mml US, INC. | $13.63 | 2025 | Reactiv8 |
| Vertos Medical, INC. | $10.54 | 2024 | Mild Device Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anand Prem listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.